tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Psychedelic: Compass Pathways, GH Research report Q3 earnings
PremiumThe FlyPsychedelic: Compass Pathways, GH Research report Q3 earnings
26d ago
Bright Minds Biosciences’ Promising Pipeline and Strategic Expansion Justify Buy Rating
Premium
Ratings
Bright Minds Biosciences’ Promising Pipeline and Strategic Expansion Justify Buy Rating
3M ago
Psychedelic: Cybin completes enrollment in CYB004 Phase 2 study
Premium
The Fly
Psychedelic: Cybin completes enrollment in CYB004 Phase 2 study
3M ago
Bright Minds Biosciences: Advancing Breakthrough Epilepsy Treatment with BMB-101 and Strong Financial Position
PremiumRatingsBright Minds Biosciences: Advancing Breakthrough Epilepsy Treatment with BMB-101 and Strong Financial Position
4M ago
Bright Minds Biosciences Reports Q3 2025 Financial Results
Premium
Company Announcements
Bright Minds Biosciences Reports Q3 2025 Financial Results
4M ago
Psychedelic: atai Life Sciences, Cybin report earnings results
Premium
The Fly
Psychedelic: atai Life Sciences, Cybin report earnings results
4M ago
Bright Minds Biosciences: Buy Rating Issued on Promising Potential of BMB-101 for Absence Seizures
PremiumRatingsBright Minds Biosciences: Buy Rating Issued on Promising Potential of BMB-101 for Absence Seizures
7M ago
Bright Minds Biosciences Hosts Virtual R&D Day on Absence Epilepsy
Premium
Company Announcements
Bright Minds Biosciences Hosts Virtual R&D Day on Absence Epilepsy
7M ago
Bright Minds announces speakers for Absence epilepsy R&D Day
Premium
The Fly
Bright Minds announces speakers for Absence epilepsy R&D Day
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100